Session V: Nano-immune interaction
09:00 - 10.30
Session Chair: Vitor Puntes,n ICN2, Spain
09.00 - 09.30 Rob Vandebriel, National Institute for Public Health & Environment, The Netherlands
The crystal structure of TiO2 nanoparticles influences immune activity in vitro and in vivo
09.30 - 09.50 (Short talk) Inés Mottas, Univeristy of Fribourg, Switzerland
Validating the biocompatibility of nanoparticles as drug carriers for immune modulation by flow cytometry: the one plate/one day method
09.50 - 10.10 (Short talk) Karolina Rudnicka, University of Lodz, Poland
The model THP1BlueCellsTM as a new tool for immune biocompatibility testing
10.10 - 10.30 (Short talk) Guilherme F.B. Lenz e Silva, University of Sao Paulo, Brazil
Assessment of nanocarbon materials using a multicriteria method based on AHP-Analytical Hierarchy Process
10.30 - 11.00 Coffee break
Session VI: Networking and Foresight
11.00 - 12.30
Chair: Donald A. Tomalia, NanoSyntons, USA
11.00 - 12.30 Round Table: Nano-immune interactions: economics of nanomedicine development, models and methods for testing efficacy and safety, and future perspectives
Participants: S. Moein Moghimi, University of Copenhagen, Denmark; Donald A. Tomalia, NanoSyntons, USA; Shadi Farhangrazi, Biotrends International, USA; Diana Boraschi, National Research Council, Italy; Laura Canesi, University of Genova, Italy; In-Hong Choi, Yonsei University College of Medicine, Korea; Lea Ann Dailey, King’s College London, UK; Socorro Espuelas, Universidad de Navarra, Spain; Cornelia M. Keck, Fachhochschule Kaiserslautern, Germany; Giovanni Pacini, ESF expert; Victor F. Puntes, ICN2, Spain
13.00 Lunch
Session VI: Networking and foresight (Continued)
15.00 - 16.30
Session Chair: Donald A. Tomalia, NanoSyntons, USA
15.00-16.30 Forward Look plenary discussion